Category Medicine and Healthcare

DEA in Marijuana Crisis: Calls for Termination of Key Officials Amid Constitutional Defiance, Ethical Violations, and Marijuana Bias
Press Release

DEA in Marijuana Crisis: Calls for Termination of Key Officials Amid Constitutional Defiance, Ethical Violations, and Marijuana Bias

The DEA's In-House Forum Takes Another Hit

While the Department of Justice has withdrawn its defense of the DEA, the DEA continues to conduct hearings under this unconstitutional framework. Attorney General Pam Bondi wrote in her recent notice to the courts:

"The Department has reviewed recent Supreme Court precedent and concluded that the existing structure of DEA's ALJs does not meet constitutional muster. Effective immediately, we will no longer defend this system in litigation and have notified federal courts accordingly."

Read More
DEA's War on Marijuana Science: How Bureaucratic Clowns Are Blocking Clinical Trials While Spreading Fear Based Fiction
Press Release

DEA's War on Marijuana Science: How Bureaucratic Clowns Are Blocking Clinical Trials While Spreading Fear Based Fiction

Duane Boise MMJ CEO opined “Now all eyes turn to DEA Administrator-nominee Terrance Cole. Thus far, his public marijuana statements have been evasive, his confirmation answers noncommittal, and his track record steeped in anti-cannabis fearmongering. However, as the DEA boss, he needs to stop the clown show in comparing cannabis to methamphetamine with no clinical basis and distributing memes claiming cannabis lowers sperm count by 50%, despite contradictory evidence”.

Read More
DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?
Press Release

DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?

"The Drug Enforcement Administration (DEA) is embroiled in a glaring contradiction: While federally compliant medical cannabis researchers like MMJ BioPharma Cultivation remain paralyzed by bureaucratic delays, U.S. recreational cannabis companies are openly exporting products, intellectual property and money to Europe-flouting federal law with no DEA intervention", stated Duane Boise, CEO MMJ. This double standard exposes a system prioritizing corporate profits over scientific progress and public health, undermining the DEA's mandate under the Controlled Substances Act (CSA).

Read More